financetom
Business
financetom
/
Business
/
Phreesia Insider Sold Shares Worth $592,424, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Phreesia Insider Sold Shares Worth $592,424, According to a Recent SEC Filing
Jan 22, 2025 2:28 PM

05:02 PM EST, 01/22/2025 (MT Newswires) -- Chaim Indig, Director, Chief Executive Officer, on January 21, 2025, sold 21,692 shares in Phreesia ( PHR ) for $592,424. Following the Form 4 filing with the SEC, Indig has control over a total of 1,492,538 shares of the company, with 1,237,538 shares held directly and 255,000 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1412408/000112760225001743/xslF345X05/form4.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Fortuna Mining Gains Nearly 5% as Swings to a fourth-Quarter Profit on Higher Sales
Update: Fortuna Mining Gains Nearly 5% as Swings to a fourth-Quarter Profit on Higher Sales
Mar 6, 2025
12:07 PM EST, 03/06/2025 (MT Newswires) -- (Updates shares.) Fortuna Mining ( FSM ) late on Wednesday reported that it swung to a fourth-quarter profit on higher revenue. The company said it earned US$11.3 million, or US$0.04 per share, swinging from a loss of US$92.3 million, or US$0.30, in the year-prior quarter. Adjusted profit, excluding most one-time items, rose to...
Update: Truist Raises PT on Jazz Pharmaceuticals to $230 From $220 on Heels of Announced Purchase of Chimerix, Keeps Buy Rating
Update: Truist Raises PT on Jazz Pharmaceuticals to $230 From $220 on Heels of Announced Purchase of Chimerix, Keeps Buy Rating
Mar 6, 2025
12:00 PM EST, 03/06/2025 (MT Newswires) -- (Updated to include analyst commentary) Truist Securities raised Jazz Pharmaceuticals ( JAZZ ) price target to $230 from $220 following the company's decision to acquire Chimerix in an all-cash deal worth $935 million, or $8.55 per share. In a March 5 report, the brokerage wrote that it sees the acquisition as exciting and...
Campbell's Fiscal Q2 Weighed Down by 'Challenging' Environment as Macro Headwinds Persist, RBC Says
Campbell's Fiscal Q2 Weighed Down by 'Challenging' Environment as Macro Headwinds Persist, RBC Says
Mar 6, 2025
12:03 PM EST, 03/06/2025 (MT Newswires) -- Campbell's (CPB) lowered its full-year forecast following a challenging fiscal Q2, as macro and consumer headwinds continue to pressure performance, RBC Capital Markets said in a note Thursday. The company lowered its fiscal 2025 outlook, now expecting adjusted EPS of $2.95 to $3.05, down from its prior range of $3.12 to $3.22. The...
JFB Construction Falls in Nasdaq Debut After Pricing IPO
JFB Construction Falls in Nasdaq Debut After Pricing IPO
Mar 6, 2025
12:13 PM EST, 03/06/2025 (MT Newswires) -- JFB Construction Holdings (JFB) fell by more than 13% in its Nasdaq debut on Thursday after raising nearly $5.2 million in its initial public offering. The company sold 1.25 million units at $4.125 per apiece, with each unit consisting of one common share and a warrant to buy an additional share, exercisable at...
Copyright 2023-2026 - www.financetom.com All Rights Reserved